M. Graf

No difference in 30-day outcome and quality of life in transradial versus transfemoral access - Results from the German Austrian ABSORB registry (GABI-R).

S. Achenbach, J. Mehilli, T. Riemer, 2021, Cardiovascular revascularization medicine : including molecular interventions.

Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)

C. Hamm, J. Wöhrle, J. Torzewski, 2020, International journal of cardiology. Heart & vasculature.

C-Reactive Protein in Human Atherogenesis: Facts and Fiction

Zhongmin Liu, J. Torzewski, K. Li, 2014, Mediators of inflammation.

Inhibiting C-Reactive Protein Synthesis by Cardiac Glycosides in Humans

J. Torzewski, O. Zimmermann, M. Zaczkiewicz, 2016 .

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

J. Torzewski, B. Mayer, O. Zimmermann, 2022, Journal of clinical medicine.

Takotsubo Syndrome After Cardiopulmonary Resuscitation During Emergency Cesarean Delivery.

M. Karch, R. Felberbaum, K. Kraft, 2017, Obstetrics and gynecology.